FedEx released its Q1 FY2019 results on September 17 and the stock pulled back ~5.5%. The stock price has subsequently recovered slightly but still remains in 'fairly valued' territory. Summary FDX released its Q1 2019 results on September 17th which reflected adjusted earnings of $3.46/share versus a forecast of $3.80/share. Revenue of $17.18B exceeded expectations [...]
Korn/Ferry International released its Q1 FY2019 results on September 6 and the stock pulled back ~24%. Results were negatively impacted by $106.6 million in trade name write-offs as part of an organizational restructuring which management had communicated to the investment community in June 2018. I view Mr. Market as having presented a buying opportunity in [...]
Thermo Fisher Scientific's annual revenue of ~$23B is nearly double that reported in FY2011. This growth has been achieved through a series of acquisitions. While there are several tailwinds supporting management's 3 - 5% annual growth projections there are various short-term headwinds. This article looks at whether Thermo Fisher is currently fairly valued and whether [...]
Summary In my March 22 article I indicated I viewed the pullback in ATD’s stock price as a window of opportunity to acquire shares in ATD at a favorable valuation; I acquired another 500 shares for the FFJ Portfolio. That article was followed up with my July 10 article in which I made a similar [...]
The Big 5 Canadian banks have recently released their Q3 results. In this article I compare the 5, 10, 15, and 20 year returns for all 5 and provide my opinion on the order of preference in which I would acquire shares. Summary A comparison of the 5, 10, 15, and 20 year returns [...]
This is my August 2018 FFJ Portfolio dividend income update. The portfolio was created in January 2017 for the purpose of demonstrating how investing in well managed companies with competitive advantages can assist investors in reaching their long-term financial goals without the need to speculate or to chase dividend yield. August was a relative [...]
Constellation Brands is currently awaiting regulatory approval to increase its stake from ~10% to 38% in Canopy Growth, Canada's premier legal cannabis manufacturer. Due to the uncertainty as to how this industry will evolve, I am reluctant to take a direct position in any cannabis producer. I do, however, wish to have some exposure to [...]
Hormel Foods, the maker of SPAM and Skippy Peanut Butter, released its Q3 results on August 23. This article is an update to my February 22 and May 24 articles. Summary HRL is transitioning from low margin commodity related businesses to higher margin branded value added products. Brands with a long history in North [...]
This is a follow up to my August 21st J.M. Smucker Company article in which I explained how I am employing the use of a conservative call option strategy to generate additional income while I patiently wait for this company's restructuring efforts to pan out. My objective, albeit ambitious, is to generate ~$7,390 in dividend [...]
The J.M. Smucker Company is currently transforming its business and the investment community has not reacted kindly to the speed at which this transformation is occurring and level of progress made to date. As a result, shares have come under pressure. While investors wait for this transformation to generate the desired results, there is a [...]
